Viridian Therapeutics, INC.
Doing business as C. T. CORPORATION SYSTEM (Previous Legal)
At a glance
Employees100-499
In business sinceNot reported
HeadquartersWaltham, MA
US patents3
SAM.gov UEIU2XJTSKPT4G3
CAGE code1AES6
Incorporated inDE
LEI549300C775BNYF550E70
- treatments
- autoimmune diseases
- antibody discovery
- engineering
- thyroid eye disease
- clinical trials
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
3 US patents granted 2023–2025, 3 of them in the five years to SEP 2025.
Pharmaceuticals 3
- Compositions, doses, and methods for treatment of thyroid eye diseaseUS 12,404,337 · granted SEP 2, 2025
- Compositions and methods for treatment of thyroid eye diseaseUS 12,404,335 · granted SEP 2, 2025
- Compositions and methods for treatment of thyroid eye diseaseUS 11,548,951 · granted JAN 10, 2023
Granted to Viridian Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Viridian Therapeutics, INC. | Waltham | MA | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.